News & Updates
Showing Endocrinology articles
Showing
Show Multimedia Only

Novel tri-agonist confers significant gains for MASLD patients
24 Nov 2023
byAudrey Abella
In a substudy of a phase II obesity trial, individuals with MASLD* and obesity benefited significantly from retatrutide, a once-weekly, injectable, novel synthetic molecule that has shown potent agonist action at GIP**, GLP-1***, and glucagon receptors.
24 Nov 2023

Meal replacement-based diet beneficial to T2D patients
22 Nov 2023
A dietary pattern based on meal replacement (MR), compared with conventional diabetic diets (CDs), brings about improvements in glycaemic control and adipose indicators in patients with type 2 diabetes (T2D), according to a study.
22 Nov 2023

Healthy lifestyle helps prevent CHD despite genetic susceptibility to obesity
19 Nov 2023
People with high or medium genetic risk of abdominal obesity but who have a healthy lifestyle are less likely to develop coronary heart disease (CHD) than those with low genetic risk and an unhealthy lifestyle, a study has shown.
19 Nov 2023






